about
The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancerGene expression profiling predicts clinical outcome of prostate cancerSuppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesMolecular pathology of prostate cancerRole of desumoylation in the development of prostate cancerGenetic alteration and gene expression modulation during cancer progressionEmerging critical role of molecular testing in diagnostic genitourinary pathologyQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingMYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation.FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Role of the TMPRSS2-ERG gene fusion in prostate cancerDownregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factorTriptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expressionMass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells.BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerIntegrative molecular concept modeling of prostate cancer progression.Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomyThe Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer.Skin Manifestation of Unsuspecting Prostate Cancer Detected by 18F-FDG PET/CT Performed To Assess Underlying Multiple MyelomaRelationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publicationsThe Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesisHey1, a mediator of notch signaling, is an androgen receptor corepressorGCPII imaging and cancer.Lower gastrointestinal tract cancer predisposition syndromesThe aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostatesAn 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.Molecular genetics of prostate cancer: new prospects for old challengesTargeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.The pathogenesis of prostate cancer: from molecular to metabolic alterations.Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.Identification of patients at risk for hereditary colorectal cancerTransition of a clinical trial into translational research: the prostate cancer prevention trial experience.Integrative analysis of prostate cancer aggressiveness.p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.Downregulation of EphA5 by promoter methylation in human prostate cancer.Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry.Defining aggressive prostate cancer using a 12-gene model.Methylation of the SLC6a2 gene promoter in major depression and panic disorderA novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.
P2860
Q24339317-C65EA6B4-5512-4440-AD20-E499B9A5CD92Q24594253-CB6197A1-F42C-40DD-83F3-024D02347334Q24656365-22D97219-8F15-4469-85CC-E3ABED560F10Q24672410-B291640A-0F21-41FF-8EC7-C05FA36E50BEQ24676101-647DF6B8-8704-422C-A14E-875D4373E068Q24798750-5156F6DD-1C25-40A9-BC1C-C79815349A2EQ27021371-475A7749-A1CA-4F68-AAAD-0030B2FF472DQ27023605-933BE047-8D8E-4261-9CE5-24AA10BE14DCQ27314468-BC88FC62-CA1B-4F51-B1CA-B5C9FE8CC6C0Q27851411-3A362F9D-A7BF-4934-88C1-C7B279F51604Q28269156-CF00A7A7-9354-4ED2-99F3-40B8B56BC895Q28474504-40A66925-95CD-4227-A29E-74D2228499E2Q28484018-74C5C7CC-01AC-465D-B29E-B7278A403CA1Q30159530-DDCA1EE4-BDF2-4669-8165-8001363AF15AQ33252066-C834B1EB-82C1-4C98-9CC3-A443C2A194F3Q33266777-06B13996-F104-4789-AB51-6389D5F30C35Q33607833-A96F5514-B51F-45B9-99BF-E0BDF0A8B05AQ33649507-424D22BA-671F-4EA6-8123-7C9CA668E040Q33669848-1B7FC2F0-E6CF-4EBD-961E-C009C857471AQ33672581-6B643E2E-A398-4842-892F-D5D02C7BDC23Q33769624-228B4753-958D-478C-89C6-DD3D5B5E47BCQ33823680-86D5A8B3-5930-4313-BD33-E1F34244ACB4Q33827632-9DAEE134-0EDE-4831-9255-FC811355AE60Q33920573-A7F10B33-4BDE-4738-B870-C7D60BA9AF4EQ33986252-FB5611A0-BD06-4932-9804-CF8B2A574BAFQ34085123-75CB8933-B87F-4284-9806-FC6E9F8D769AQ34109986-00B0433A-F0FB-4F72-96ED-7585F903A435Q34127462-E91F4F0F-2DF9-469A-8393-B5BED9A7AC26Q34173253-4A34D6F5-1689-41F0-BE46-549644EB8E5EQ34201846-12FBA11F-ED4A-4AD0-9C9C-1E25B3738D86Q34497901-3650A518-14ED-49AC-9DD5-B61C6E3AF287Q34652530-BBB1195D-1DBC-42E8-9530-D7DE772600B6Q34682926-E7823DFC-491A-4B38-BC34-79FA13930843Q34787486-F320C595-16D1-420E-9EE5-D1CE1A4561D9Q34997026-8C1C4A2D-B353-4B63-B994-4A4CCC391AB5Q35017605-3A90D7C0-D120-40B6-BC2D-9A563AE73452Q35040172-197D3E3C-BF50-42AF-B463-1D6EBB0EBAD5Q35060298-6A77116F-5004-4B3D-B72C-B7926B42DBCEQ35061589-6423B2E9-E2B1-4EE8-8C20-E638AC43B0E7Q35112837-4A4A1685-ADA8-4AC3-8382-401A09AD693A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathological and molecular aspects of prostate cancer.
@ast
Pathological and molecular aspects of prostate cancer.
@en
type
label
Pathological and molecular aspects of prostate cancer.
@ast
Pathological and molecular aspects of prostate cancer.
@en
prefLabel
Pathological and molecular aspects of prostate cancer.
@ast
Pathological and molecular aspects of prostate cancer.
@en
P2093
P1433
P1476
Pathological and molecular aspects of prostate cancer.
@en
P2093
Angelo M DeMarzo
Jonathan I Epstein
William B Isaacs
William G Nelson
P304
P356
10.1016/S0140-6736(03)12779-1
P407
P577
2003-03-01T00:00:00Z